Published in J Clin Microbiol on July 01, 2000
Lassa fever in post-conflict sierra leone. PLoS Negl Trop Dis (2014) 2.23
Lassa fever: epidemiology, clinical features, and social consequences. BMJ (2003) 2.06
Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study. Virol J (2011) 1.47
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27
On the front lines of Lassa fever. Emerg Infect Dis (2004) 1.24
Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol J (2008) 1.10
Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis (2010) 0.99
Mapping transmission risk of Lassa fever in West Africa: the importance of quality control, sampling bias, and error weighting. PLoS One (2014) 0.99
Molecular determinants of Pichinde virus infection of guinea pigs--a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci (2009) 0.97
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virol J (2010) 0.92
Early-onset sensorineural hearing loss in Lassa fever. Eur Arch Otorhinolaryngol (2010) 0.91
Advanced vaccine candidates for Lassa fever. Viruses (2012) 0.90
Laboratory diagnosis of Lassa fever, liberia. Emerg Infect Dis (2010) 0.87
Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses (2012) 0.84
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Am J Trop Med Hyg (2013) 0.84
Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virol J (2010) 0.83
Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms. Virol J (2009) 0.81
Short Report: Serological Evidence of Under-Reported Dengue Circulation in Sierra Leone. PLoS Negl Trop Dis (2016) 0.79
Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection. BMC Genomics (2014) 0.79
Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone. Trans R Soc Trop Med Hyg (2014) 0.78
Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification. Microbiol Immunol (2011) 0.78
The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection. Niger Med J (2012) 0.77
Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccines (Basel) (2013) 0.76
Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol (2015) 0.75
Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers. PLoS Negl Trop Dis (2017) 0.75
Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull World Health Organ (1975) 6.81
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg (1970) 4.96
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol (1994) 2.65
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
Lassa fever. A study of 23 hospital cases. Trans R Soc Trop Med Hyg (1972) 2.37
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 1.91
Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ (1979) 1.80
Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol (1998) 1.77
Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg (1993) 1.66
Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol (1990) 1.61
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. J Immunol (1984) 1.59
Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol (1984) 1.47
Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24
Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody. Lancet (1985) 1.12
Clinical features of Lassa fever in Liberia. Rev Infect Dis (1989) 1.08
Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop Geogr Med (1986) 1.03
Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans R Soc Trop Med Hyg (1984) 1.03
Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 0.97
A serological survey of Lassa fever in Liberia. Bull World Health Organ (1978) 0.95
Unexpected adverse reactions during a clinical trial in rural west Africa. Antiviral Res (1992) 0.87
Effects of exposure to high concentrations of ribavirin in developing embryos. Pediatr Infect Dis J (1990) 0.82
[Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers]. Vopr Virusol (1986) 0.81
A neutralization test survey for Lassa Fever activity in Lassa, Nigeria. Trans R Soc Trop Med Hyg (1977) 0.80
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg (1981) 3.72
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol (1985) 3.06
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95
Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
The pyrethroid knock-down resistance gene in the Anopheles gambiae complex in Mali and further indication of incipient speciation within An. gambiae s.s. Insect Mol Biol (2003) 2.53
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis (2007) 2.37
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect (2001) 2.30
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis (1997) 2.19
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17